This book is a unique, comprehensive board review dedicated solely to preventive cardiology. This volume is a companion work to the ASPC Manual of Preventive Cardiology. The book is comprised of a series of questions, each which addresses a core issue in preventive cardiology. Each question is accompanied with a correct answer key as well as a discussion of why the chosen response is correct, and the others are incorrect. Answers are supported by illustrations and discussion of contemporary literature when applicable. The book also provides references for additional study. This book contains questions written by many of the original authors who contributed to the ASPC Manual of Preventive Cardiology. This book, along with the ASPC Manual of Preventive Cardiology, accompanies the ASPC Experts Course in Preventive Cardiology.

The ASPC Self-Assessment Program in Preventive Cardiology is a valuable resource for cardiologists and other specialists, as well as primary care clinicians (including internists, family physicians, nurse practitioners, and physician assistants) who seek additional training and expertise in cardiovascular disease prevention.

The first board review to be solely dedicated to preventive cardiology Offers a comprehensive review that addresses core issues in preventive cardiology Discusses each core issue in a question and answer format with supporting illustrations

Autorentext
Nathan D. Wong is a cardiovascular epidemiologist and professor and director of the Heart Disease Prevention Program in the Division of Cardiology at the University of California, Irvine School of Medicine. He has published over 400 papers and 8 books. He is an editor of the ASPC Manual of Preventive Cardiology and co-editor in chief of the American Journal of Preventive Cardiology. He is a former president of the ASPC.

Ezra A. Amsterdam is a clinical cardiologist at the University of California, Davis. He is a Distinguished Professor of Medicine (Cardiology), Master Clinician, has published over 800 papers including 15 books, has received 48 honors and awards for his teaching and research from American and international organizations and chaired or contributed to multiple cardiology guidelines. He is an editor of the ASPC Manual of Preventive Cardiology and past president of the ASPC.

Peter P. Toth is a primary care physician with multiple academic affiliations. He has published 420 papers and 23 books. He is Series Editor for Springer's Contemporary Cardiology series and was also an editor of the ASPC Manual of Preventive Cardiology. He is a past president of the ASPC. Dr. Toth has published 8 books with Springer.

Inhalt

Chapter 1 National and Global Trends of Cardiovascular Disease Mortality, Morbidity, and Risk.- Chapter 2 Cardiovascular Risk Assessment: From Global Risk Scoring to Risk Enhancing Factors.- Chapter 3 Assessment and Management of Psychosocial Risk Factors Within Preventive Cardiology Practice.- Chapter 4 Dietary Strategies for Atherosclerotic Cardiovascular Risk Reduction.- Chapter 5 Physical Activity Strategies.- Chapter 6 Obesity Management and Prevention of Cardiovascular Disease.- Chapter 7 Smoking and Vaping.- Chapter 8 Alcohol and Cardiovascular Diseases.- Chapter 9 The 2018 AHA/ACC/Multisociety Cholesterol Guidelines: A Personalized Approach to Risk Reduction.- Chapter 10 Blood Pressure and Hypertension Management.- Chapter 11 Cardiodiabetology Reducing Risks to Optimize.- Chapter 12 Cardiovascular Disease Outcomes.- Chapter 13 Antiplatelet Therapy.- Chapter 14 Inflammation and Atherosclerotic Cardiovascular Disease.- Chapter 15 The Role of Genetics in Preventive Cardiology: Utility of Clinically Available Genetic Tests.- Chapter 16 Exercise Electrocardiographic Stress Testing.- Chapter 17 Ultrasound and MRI Assessment of Cardiovascular Risk.- Chapter 18 Role of CT Coronary Calcium Scanning and Angiography in Evaluation of Cardiovascular Risk.- Chapter 19 Cardiovascular Disease Prevention in Women.- Chapter 20 Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease.- Chapter 21 Prevention of Heart Failure.- Chapter 22 Prevention of Peripheral Arterial Disease.- Chapter 23 Prevention of Atrial Fibrillation.- Chapter 24 Prevention of Ischemic Stroke.- Chapter 25 Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease.- Chapter 26 Primary Prevention of Cardiovascular Disease Guidelines.- Chapter 27 Secondary Prevention and Cardiac Rehabilitation.- Chapter 28 Integrative Approaches for Cardiovascular Disease Prevention.- Chapter 29 Lipoprotein.- Chapter 30 Safety of Ultra-Low Low-density Lipoprotein Cholesterol.- Chapter 31 COVID-19 Infection and Cardiovascular Complications.- Chapter 32 Insulin Resistance.- Chapter 33 Epicardial Steatosis.- Chapter 34 Endothelial Cell Dysfunction.